AI Article Synopsis
- Primary signet ring cell carcinoma (SRCC) of the breast is a rare and aggressive type of breast cancer with a high risk of metastasis and poor prognosis.
- A 56-year-old woman presented with breast retraction, and imaging revealed a mass, leading to a left modified radical mastectomy, which showed 70% signet ring cell pattern in pathology.
- The patient was treated with an adriamycin-cyclophosphamide chemotherapy regimen, and this case aims to review the literature to inform physicians about SRCC.
Article Abstract
Primary signet ring cell carcinoma (SRCC) of the breast is a rare and aggressive type of breast cancer characterized by increased intracellular mucin production. It has a high risk of metastasis and poor prognosis compared to other breast cancer types. We report a 56-year-old woman with primary SRCC of the breast who first presented with retraction on her left breast. Radiological examination revealed a mass that causes the retraction. The patient underwent left modified radical mastectomy, and pathology results showed a 70% signet ring cell pattern. Chemotherapy consists of an adriamycin-cyclophosphamide regimen administered. in this case, we aim to review the literature on this topic and inform the physicians.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4103/jcrt.jcrt_1963_22 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!